Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Optic Nerve Diseases: early-phase trial registry
2 of 3 indexed Optic Nerve Diseases trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Optic Nerve Diseases: 3 US clinical trials tracked, 2 recruiting.
Optic Nerve Diseases is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition optic-nerve-diseases
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Optic Nerve Diseases lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Optic Nerve Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Optic Nerve Diseases is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Electrical Stimulation for the Treatment of Optic Neuropathies
Stanford University
NCT05626426
Optimize Pediatric OCT Imaging
Duke University
NCT06139523
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NCT01404247
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Optic Nerve Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Optic Nerve Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Optic Nerve Diseases page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Optic Nerve Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center sponsors the most Optic Nerve Diseases trials on record, review their full trial history before evaluating a specific study. See Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Optic Nerve Diseases condition card totals 3 registered trials; most-linked intervention OCT imaging.; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.